US2001021396A1PendingUtilityA1
Method for treating symptoms of the onset of menopause using chromium
Priority: Jul 28, 1997Filed: May 17, 2001Published: Sep 13, 2001
Est. expiryJul 28, 2017(expired)· nominal 20-yr term from priority
Inventors:Malcolm N. Mcleod
A61K 33/24
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The method of this invention is directed to a treatment of alcohol craving in men and women and to a treatment of pre-menstrual syndrome (PMS) in women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form either alone or in conjunction with the administration of a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating alcohol craving in a patient, the method comprising the steps of (a) administering a therapeutically effective amount of chromium in a pharmaceutically acceptable form to a patient in need thereof; and (b) relieving alcohol craving in the patient by said administering of said therapeutically effective amount of chromium.
2 . The method according to claim 1 wherein chromium is administered in a dose ranging from about 50 μg to about 1,000 μg daily.
3 . The method according to claim 2 wherein chromium is administered in a dose ranging from about 100 μg to about 600 μg daily.
4 . The method according to claim 3 wherein chromium is administered in a dose ranging from about 200 μg to about 500 μg daily.
5 . The method according to claim 1 wherein the therapeutically effect amount is administered at least once a day.
6 . The method according to claim 1 wherein the therapeutically effect amount is administered at least twice a day.
7 . The method according to claim 1 wherein the therapeutically effect amount is administered three times a day.
8 . The method according to claim 1 wherein chromium is administered in a dose ranging from about 1 μg to about 10 μg per kilogram body weight of the patient daily.
9 . The method according to claim 8 wherein chromium is administered in a dose ranging from about 2 μg to about 8 μg per kilogram body weight of the patient daily.
10 . The method according to claim 9 wherein chromium is administered in a dose ranging from about 4.5 μg to about 6 μg per kilogram body weight of the patient daily.
11 . A method of treating alcohol craving in a patient, the method comprising the steps of (a) administering a therapeutically effective amount of chromium in a pharmaceutically acceptable form to a patient in need thereof, said treating of alcohol craving being free of administering to the patient other compositions to treat alcohol craving; and (b) relieving alcohol craving in the patient by said administering of said therapeutically effective amount of chromium.
12 . The method according to claim 11 wherein chromium is administered in a dose ranging from about 50 μg to about 1,000 μg daily.
13 . The method according to claim 12 wherein chromium is administered in a dose ranging from about 100 μg to about 600 μg daily.
14 . The method according to claim 13 wherein chromium is administered in a dose ranging from about 200 μg to about 500 μg daily.
15 . The method according to claim 11 wherein the therapeutically effect amount is administered at least once a day.
16 . The method according to claim 11 wherein the therapeutically effect amount is administered at least twice a day.
17 . The method according to claim 11 wherein the therapeutically effect amount is administered three times a day.
18 . The method according to claim 11 wherein chromium is administered in a dose ranging from about 1 μg to about 10 μg per kilogram body weight of the patient daily.
19 . The method according to claim 18 wherein chromium is administered in a dose ranging from about 2 μg to about 8 μg per kilogram body weight of the patient daily.
20 . The method according to claim 19 wherein chromium is administered in a dose ranging from about 4.5 μg to about 6 μg per kilogram body weight of the patient daily.Join the waitlist — get patent alerts
Track US2001021396A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.